Skip to main content

Table 1 Baseline demographic and clinical characteristics (safety set)

From: Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study

Demographic and clinical characteristics

Quetiapine XR + Lithium (n= 173)

Quetiapine XR + Placebo (n= 183)

Total (n= 356)

Age (years)

   

 Mean (SD)

37.9 (12.7)

38.8 (12.1)

38.3 (12.4)

 Median

37.0

38.0

37.0

 Range (min, max)

18, 64

18, 65

18, 65

Gender, n (%)

   

 Male

101 (58.4)

121 (66.1)

222 (62.4)

 Female

72 (41.6)

62 (33.9)

134 (37.6)

Race, n (%)

   

 White

98 (56.6)

102 (55.7)

200 (56.2)

 Asian

73 (42.2)

78 (42.6)

151 (42.4)

 Other

2 (1.2)

3 (1.6)

5 (1.4)

Weight (kg)

   

 Mean (SD)

69.1 (15.9)

71.0 (17.1)

70.1 (16.5)

 Median

68.0

69.0

68.0

 Range (min, max)

37, 120

37, 115

37, 120

BMI (kg/m2)

   

 Mean (SD)

24.3 (4.3)

24.9 (5.2)

24.6 (4.8)

 Median

23.8

24.1

23.9

 Range (min, max)

15.8, 37.1

14.7, 43.8

14.7, 43.8

Psychiatric diagnosis, n (%)

   

 Most recent episode manic

159 (91.8)

173 (94.5)

332 (93.3)

 Most recent episode mixed

14 (8.1)

10 (5.5)

24 (6.7)

Rapid cycling, n (%)

   

 Yes

3 (1.7)

5 (2.7)

8 (2.2)

 No

170 (98.3)

178 (97.3)

348 (97.8)

Time since first diagnosis of acute mania, years

   

 Mean (SD)

7.1 (6.6)

7.8 (7.0)

7.5 (6.8)

Time since first mania/mixed episode, years

   

 Mean (SD)

7.2 (6.6)

8.1 (7.0)

7.7 (6.8)

Total number of mania/mixed episodes in the past year, n (%)

   

 0

56 (32.4)

56 (30.6)

112 (31.5)

 1

88 (50.9)

88 (48.1)

176 (49.4)

 ≥ 2

29 (16.8)

39 (21.3)

68 (19.1)

Previous medication use, n (%)

   

 Lithium

4 (2.3)

2 (1.1)

6 (1.7)

 Quetiapine

8 (4.6)

17 (9.3)

25 (7.0)